Terns Pharmaceuticals Inc (TERN)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
CEO:
Senthil Sundaram
Employees:
40
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY, CA 94404
650-525-5535 EXT.101

Terns Pharmaceuticals, Inc. develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.

Data derived from most recent annual or quarterly report
Market Cap 76.343 Million Shares Outstanding25.279 Million Avg 30-day Volume 344.205 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-37.82
Price to Revenue62.9023 Debt to Equity0.0 EBITDA-51.521 Million
Price to Book Value0.4584 Operating Margin-5365.5 Enterprise Value-76.908 Million
Current Ratio23.594 EPS Growth0.932 Quick Ratio23.132
1 Yr BETA 0.9287 52-week High/Low 13.77 / 1.45 Profit Margin-5378.6
Operating Cash Flow Growth-17.5033 Altman Z-Score2.825 Free Cash Flow to Firm -38.717 Million
Earnings Report2022-08-15
View SEC Filings from TERN instead.

View recent insider trading info

Funds Holding TERN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TERN

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TRIPURANENI RADHIKA

0 2022-07-26 2

RUSSELL KERRY STRONG CHIEF MEDICAL OFFICER

240,000 2022-07-01 2

FELLOWS DAVID A

32,000 2022-06-16 2

KINDLER JEFFREY B

32,000 2022-06-16 2

GORDON CARL L

32,000 2022-06-16 1

LU HONGBO

32,000 2022-06-16 1

QUIGLEY JILL M.

32,000 2022-06-16 2

TAYLOR ANN ELIZABETH

32,000 2022-06-16 3

YOON SEOKHO BRYAN COO AND GENERAL COUNSEL

7,656 2022-05-31 3

SUNDARAM SENTHIL VEL CHIEF EXECUTIVE OFFICER

7,656 2022-05-31 3

VIGNOLA MARK J. CHIEF FINANCIAL OFFICER

7,656 2022-05-31 3

QUIRK ERIN PRESIDENT, CMO AND HEAD OF R&D

  • Officer
92,500 2022-01-26 2

FLYNN JAMES E

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD PARTNERS, L.P.

DEERFIELD MGMT L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2021-02-09 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VII LLC

ORBIMED ASIA GP III, L.P.

ORBIMED ADVISORS III LTD

  • Director
  • 10% Owner
3,791,204 2021-02-09 0

VIVO CAPITAL VIII, LLC

VIVO CAPITAL FUND VIII, L.P.

VIVO CAPITAL SURPLUS FUND VIII, L.P.

VIVO OPPORTUNITY, LLC

VIVO OPPORTUNITY FUND, L.P.

  • 10% Owner
2,675,133 2021-02-09 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

TRIPURANENI RADHIKA

2022-07-28 20:08:05 -0400 2022-07-26 A 64,000 a 64,000 direct

RUSSELL KERRY STRONG CHIEF MEDICAL OFFICER

2022-07-06 20:07:09 -0400 2022-07-01 A 240,000 a 240,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
TERNS PHARMACEUTICALS INC TERN 2022-08-12 22:15:03 UTC 0.0875 2.2325 4000
TERNS PHARMACEUTICALS INC TERN 2022-08-12 14:45:04 UTC 0.7056 1.6144 40000
TERNS PHARMACEUTICALS INC TERN 2022-08-12 14:15:05 UTC 0.7056 1.6144 40000
TERNS PHARMACEUTICALS INC TERN 2022-08-12 13:45:04 UTC -0.1 2.42 40000
TERNS PHARMACEUTICALS INC TERN 2022-08-12 13:15:04 UTC -0.1 2.42 45000
TERNS PHARMACEUTICALS INC TERN 2022-08-12 12:45:04 UTC -0.1 2.42 35000
TERNS PHARMACEUTICALS INC TERN 2022-08-11 22:15:03 UTC -0.1 2.42 35000
TERNS PHARMACEUTICALS INC TERN 2022-08-11 21:45:04 UTC -0.1 2.42 35000
TERNS PHARMACEUTICALS INC TERN 2022-08-11 21:15:03 UTC -0.1 2.42 35000
TERNS PHARMACEUTICALS INC TERN 2022-08-11 20:45:04 UTC -0.1 2.42 35000
TERNS PHARMACEUTICALS INC TERN 2022-08-11 20:15:03 UTC -0.1 2.42 40000
TERNS PHARMACEUTICALS INC TERN 2022-08-11 19:45:04 UTC -0.1 2.42 45000
TERNS PHARMACEUTICALS INC TERN 2022-08-11 19:15:05 UTC -0.1 2.42 45000
TERNS PHARMACEUTICALS INC TERN 2022-08-11 18:45:03 UTC -0.1 2.42 45000
TERNS PHARMACEUTICALS INC TERN 2022-08-11 18:15:05 UTC -0.1 2.42 45000
TERNS PHARMACEUTICALS INC TERN 2022-08-11 17:45:05 UTC -0.1 2.42 45000
TERNS PHARMACEUTICALS INC TERN 2022-08-11 17:15:05 UTC -0.1 2.42 45000
TERNS PHARMACEUTICALS INC TERN 2022-08-11 16:45:04 UTC -0.1185 2.4385 45000
TERNS PHARMACEUTICALS INC TERN 2022-08-11 16:15:05 UTC -0.1185 2.4385 50000
TERNS PHARMACEUTICALS INC TERN 2022-08-11 15:45:05 UTC -0.1185 2.4385 45000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund TERN -100.0 shares, $-297.0 2022-03-31 N-PORT

Elevate your investments